The plant medicine bulletin for this week covers CBD and its potential to treat neuroinflammation, Alzheimer’s, chemotherapy-induced pain and oral health. It also includes updates on the DEA rescheduling process and medical cannabis at the workplace.
Please Read This
Can CBD be used to treat Alzheimer’s disease? (Dr. Andrew Weil)
Andrew Weil discusses emerging evidence showing that CBD is relevant to Alzheimer’s. This includes its impact on neuroinflammation, brain immune function and other factors. The article examines CBD as part of the larger conversation on how cannabinoids could help to protect the aging mind and support new ways to treat neurodegenerative disorders.
Continue reading the entire article
Note that MEDCAN24 conducted an interview with Dr. Weil on marijuana and integrative medicines in 2023. You can read the entire interview by clicking here.
CBD – View More in CBD
Further Reading
Medical Cannabis Cuts Employee Sick Days
Inc. reports that research shows that states with laws regulating medical marijuana have fewer sick leave days. In fact, employee absences due to health issues are down by 7%. These findings indicate that legal access could help workers manage chronic conditions and continue to work.
Click here to read more
CBD – View More in CBD
US Tobacco Giant is Behind the Planned Acquisition of Largest Licensed Dutch Cannabis Grower. (Cannabis law Report)
Cannabis Law Report highlights an upcoming takeover between the Netherlands largest cannabis producer and a major U.S. tobacco company. This story highlights the increasing interest by tobacco companies in cannabis markets that are regulated as adult and medical use systems become more mature.
Click here to read more
CBD – View More in CBD
DEA Argues In Favor Of Moving Cannabis To Schedule III (Ganjapreneur).
The DEA dragged its heels for years on cannabis rescheduling. Now it is in court, calling witnesses of its own, and arguing the rule must be implemented.
Click here to read more
THC – View the latest in THC
Research Roundup
CBD attenuates Chemotherapy Induced Neuropathic Pain
CBD has been shown to reduce peripheral neuropathic symptoms caused by chemotherapy, which is an unpleasant and frequent side-effect of cancer treatments. This study relates CBD’s pain modulating effects to endocannabinoid signaling and lipid pathways. It adds interest in using cannabinoids in cancer care.
Click here to read more
Endocannabinoid System – View the full article
CBD Mouthwash Does Not Damage Enamel or Other Materials (Marijuana Herald).
According to a recent study, a CBD mouthwash with lowered concentrations was able to reduce dental biofilms without damaging the enamel. Researchers are exploring alternatives to traditional antimicrobial ingredients and CBD could be a good option for formulations that promote oral health.
Click here to read more
CBD – View More in CBD
Acne Treatment with CBD Isolate and Cannabis Extracts Rich in CBD
In a new review, CBD-rich cannabis and CBD isolate are examined as possible tools to manage inflammatory acne. They highlight CBD’s anti-inflammatory, sebum-regulating qualities. The cannabinoid-science is now able to connect with an increasing interest in dermatology derived from plants.
Click here to read more
CBD – View More in CBD
Thank you so much to the CBD companies who generously support MEDCAN24 in bringing the latest research on plant medicine to the attention of our readers.